Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Citalopram-induced
priapism.
Dent LA, Brown WC, Murney
JD.
Department of Pharmacy Practice, School of Pharmacy and
Allied Health Sciences, University of Montana, Missoula 59812,
USA.
Citalopram is a relatively new selective serotonin reuptake
inhibitor (SSRI) that is becoming widely administered for the treatment
of depression. Selective serotonin reuptake inhibitors generally are
associated with mild adverse sexual side effects; however, more serious
reactions may occur. A 58-year-old man experienced priapism several
hours after inadvertently taking three tablets of citalopram 20 mg,
which he had mistaken for aspirin, in addition to his usual dosage of 20
mg twice/day. Three days later, he was hospitalized and treated with
intracavernous phenylephrine. He ultimately required surgical
intervention. Although the citalopram overdose appears to be largely
responsible for the patient developing priapism, he also was taking
tamsulosin 0.4 mg/day at bedtime for benign prostatic hyperplasia. As
alpha1-blockers have been associated with priapism on rare occasions,
tamsulosin may have been a contributing factor. The patient also had a
history of priapism associated with trazodone. Health care professionals
should vigilantly monitor patients who take citalopram in high dosages
or in combination with other drugs associated with priapism. Patients
who have a history of priapism with other drugs may be more susceptible
to citalopram-associated priapism.
Publication Types:
PMID: 11939691 [PubMed - indexed for
MEDLINE]
|